Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra^<TM>) in human plasma : Method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degra

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-02-15

著者

• Iacono Lisa

  Discovery Medicine And Clinical Pharmacology Research & Development

• Xu Xiaohui

  Bioanalytical Sciences Research & Development

• Arnold Mark

  Bioanalytical Sciences Research & Development

• Arnold Mark

  Bioanalytical Sciences Department Pharmaceutical Research Institute

• ZENG Jianing

  Bioanalytical Sciences Department, Pharmaceutical Research Institute

• MYLOTT William

  PPD

• WALTRIP James

  PPD

• MARIANNINO Thomas

  PPD

• STOUFFER Bruce

  Bioanalytical Sciences, Research & Development

• Stouffer Bruce

  Bioanalytical Sciences Research & Development

• Zeng Jianing

  Bioanalytical Sciences Research & Development

• Zeng Jianing

  Bioanalytical Sciences Department Pharmaceutical Research Institute

関連論文

• Development and validation of sensitive and selective LC-MS/MS methods for the determination of BMS-708163, a γ-secretase inhibitor, in plasma and cerebrospinal fluid using deprotonated or formate adduct ions as precursor ions
• Simultaneous determination of a selective adenosine 2A agonist, BMS-068645, and its acid metabolite in human plasma by liquid chromatography-tandem mass spectrometry-Evaluation of the esterase inhibitor, diisopropyl fluorophosphate, in the stabilization o
• Liquid chromatography and tandem mass spectrometry for the quantitative determination of ixabepilone (BMS-247550, Ixempra^) in human plasma : Method validation, overcoming curve splitting issues and eliminating chromatographic interferences from degra

スポンサーリンク